Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA.
Tufts University Graduate School in Biomedical Sciences, Boston, MA, USA.
Methods Mol Biol. 2021;2291:381-397. doi: 10.1007/978-1-0716-1339-9_19.
Shiga toxin-producing E. coli (STEC) is a common foodborne pathogen in developed countries. STEC generates "attaching and effacing" (AE) lesions on colonic epithelium, characterized by effacement of microvilli and the formation of actin "pedestals" beneath intimately attached bacteria. In addition, STEC are lysogenized with a phage that, upon induction, can produce potent Shiga toxins (Stx), potentially leading to both hemorrhagic colitis and hemolytic uremic syndrome. Investigation of the pathogenesis of this disease has been challenging because STEC does not readily colonize conventional mice.Citrobacter rodentium (CR) is a related mouse pathogen that also generates AE lesions. Whereas CR does not produce Stx, a murine model for STEC utilizes CR lysogenized with an E. coli-derived Stx phage, generating CR(Φstx), which both colonizes conventional mice and readily gives rise to systemic disease. We present here key methods for the use of CR(Φstx) infection as a highly predictable murine model for infection and disease by STEC. Importantly, we detail CR(Φstx) inoculation by feeding, determination of pathogen colonization, production of phage and toxin, and assessment of intestinal and renal pathology. These methods provide a framework for studying STEC-mediated systemic disease that may aid in the development of efficacious therapeutics.
产志贺毒素大肠杆菌(STEC)是发达国家常见的食源性病原体。STEC 在结肠上皮产生“黏附和消除”(AE)病变,其特征是微绒毛消失和紧密附着的细菌下方形成肌动蛋白“基座”。此外,STEC 被噬菌体溶原化,诱导后可产生强效的志贺毒素(Stx),可能导致出血性结肠炎和溶血尿毒综合征。由于 STEC 不易在常规小鼠中定植,因此该疾病的发病机制研究具有挑战性。鼠柠檬酸杆菌(CR)是一种相关的鼠病原体,也会产生 AE 病变。虽然 CR 不产生 Stx,但 STEC 的小鼠模型利用携带大肠杆菌来源的 Stx 噬菌体的 CR 溶原化,产生 CR(Φstx),它既能定植常规小鼠,又能轻易引起全身疾病。我们在此介绍了使用 CR(Φstx)感染作为 STEC 感染和疾病的高度可预测小鼠模型的关键方法。重要的是,我们详细描述了通过喂养进行 CR(Φstx)接种、确定病原体定植、噬菌体和毒素的产生以及评估肠道和肾脏病理的方法。这些方法为研究 STEC 介导的全身疾病提供了一个框架,可能有助于开发有效的治疗方法。